Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca announces breakthrough therapy status for Calquence in CLL

pharmaceutical-technologyAugust 15, 2019

Tag: AstraZeneca , CLL , Breakthrough Therapy

PharmaSources Customer Service